Madecassoside vs Asiaticoside: Which One Does Your Skin Need?
Key Facts
- Madecassoside has a molecular weight of ~975 Da, asiaticoside ~959 Da — both fall in the mid-to-large molecule range, but madecassoside's more polar structure makes it more stable in the stratum corneum.
- Madecassoside suppresses the NF-κB pathway to reduce pro-inflammatory cytokine release, while asiaticoside activates the TGF-β1 pathway to stimulate fibroblast proliferation and collagen synthesis.
- Both molecules are metabolized in skin — asiaticoside enzymatically converts to asiatic acid, and madecassoside to madecassic acid — meaning the line between them intersects at the metabolic level too.
- Formulas containing both compounds together have shown a more pronounced improvement in collagen I/III ratio compared to single-ingredient products, supporting their synergistic use for barrier repair and anti-aging.
- Full-spectrum Centella extracts contain all four triterpene compounds, but high-purity isolated madecassoside or asiaticoside produces more predictable, measurable results in clinical use.
Have a clinical question?
Consult directly with our pharmacist.
Consult via WhatsAppPharm. Mine Ekber
Centella Asiatica's Active Compounds: The Big Picture
Centella asiatica has been used in Asian medicine for centuries; but when modern dermatology truly "dissected" this plant, four main triterpene compounds emerged, each with a distinct function: madecassoside, asiaticoside, madecassic acid, and asiatic acid.
The Triterpene Family: Shared Origin, Distinct Identity
Madecassoside and asiaticoside are chemically triterpene glycosides built on an ursane skeleton. Both are bound to sugar chains made of glucose, rhamnose, and arabinose units; this glycoside structure gives them water solubility while also shaping their bioavailability. The key difference comes from an extra hydroxyl group madecassoside carries: this group gives the molecule higher polarity and makes it particularly effective in inflammation signaling.
Centella Extract or Isolated Compound?
The label "Centella asiatica extract" appears often on the market, but this label alone tells you nothing about the ratio of active compounds in the product. Quality dermocosmetic formulations, on the other hand, separately state the percentage of madecassoside or asiaticoside. While a full-spectrum Centella extract contains all four compounds, high-purity isolated madecassoside or asiaticoside produces more predictable and measurable results in clinical studies.Brinkhaus et al., 2000
| Feature | Madecassoside | Asiaticoside |
|---|---|---|
| Molecular weight | ~975 Da | ~959 Da |
| Chemical class | Triterpene glycoside | Triterpene glycoside |
| Polar hydroxyl group | Extra –OH group present | Less polar structure |
| Primary effect | Anti-inflammatory, barrier repair | Collagen synthesis, wound healing |
| Main signaling pathway | NF-κB suppression | TGF-β1 activation |
| Formulation stability | High (stable in polar media) | Moderate (metabolized enzymatically) |
Madecassoside: The Anti-Inflammatory and Barrier-Repair Specialist
Madecassoside remains Centella's most researched compound, largely thanks to its documented effectiveness in both sensitive and chronically inflamed skin. Our dedicated madecassoside guide covers all of this compound's mechanisms in depth; here, we focus on how it compares to asiaticoside.
How Does It Suppress the NF-κB Pathway?
"Nuclear factor-kappa B (NF-κB) is the master regulator of inflammatory responses in skin. When UV light, pathogens, or irritants activate this pathway, pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α are released. Madecassoside is understood to interrupt this cascade at an early stage by blocking IκBα phosphorylation, which in turn halts NF-κB's translocation into the nucleus."
Its Role in Barrier Repair
Madecassoside supports two fundamental building blocks of the skin barrier: it increases expression of the tight-junction proteins claudin-1 and filaggrin. This effect is particularly critical for rebuilding an epidermal barrier damaged by atopic dermatitis or chronic irritation. At 0.1-0.5% concentrations, it has also been shown to meaningfully reduce TEWL — documenting its role as a barrier "sealant."
Reliability in Redness-Prone and Reactive Skin
Madecassoside also calms neurogenic inflammation through its capacity to inhibit the TRPV1 (Transient Receptor Potential Vanilloid 1) channel. When this channel is activated by stimuli like heat, acids, or capsaicin, it causes burning, flushing, and itching. Madecassoside-containing formulas are thought to work through this mechanism in people with rosacea and reactive skin.
Asiaticoside: The Collagen Synthesis and Wound-Healing Specialist
Asiaticoside is more often associated with "renewal" and "regaining firmness" in skincare, because this compound's primary mechanism of action is strengthening the dermis by stimulating collagen synthesis.
Fibroblast Activation via the TGF-β1 Pathway
Asiaticoside activates TGF-β1 (Transforming Growth Factor-Beta 1) signaling in fibroblasts, increasing type I and type III collagen synthesis. Classic in vitro work on Centella asiatica triterpenes demonstrated stimulation of collagen synthesis in cultured fibroblasts.Maquart et al., 1990 This collagen-stimulating effect is what makes asiaticoside a valuable ingredient in countering age-related collagen loss.
Enzymatic Metabolism: Asiaticoside → Asiatic Acid
Once applied to skin, asiaticoside is broken down by enzymes like β-glucosidase into asiatic acid, and to a lesser extent madecassic acid. This metabolic conversion has two implications: first, asiaticoside's effectiveness partly depends on these metabolites; second, since conversion speed can vary with individual enzyme activity, onset of effect can differ from person to person. Research on asiaticoside has documented elevated antioxidant levels in healing wounds, supporting its role in the wound-repair process.Shukla et al., 1999
Asiaticoside in Hyperpigmentation and Scarring Risk
Asiaticoside's collagen-remodeling capacity has also put it on researchers' radar for acne scars, post-surgical wound care, and stretch mark prevention. Clinical use of asiaticoside-containing creams has been associated with softening of scar tissue and more even skin tone over multi-week protocols. Asiaticoside also regulates matrix metalloproteinase (MMP) activity, which helps reduce faulty collagen buildup.
Madecassoside vs Asiaticoside Comparison: Which One, When?
Positioning these two compounds as "interchangeable alternatives" is a molecular-level misunderstanding; but there are specific skin concerns where one should reasonably take priority over the other. The guide below summarizes which compound to lean on for which situation.
Madecassoside takes the lead. Its effect on the NF-κB and TRPV1 pathways rapidly calms active inflammation. First choice for rosacea, atopic flare-ups, and irritant contact dermatitis.
Asiaticoside takes precedence. Through TGF-β1 activation and fibroblast proliferation, it reshapes scar tissue; it's part of long-term use protocols for acne and surgical scars.
Madecassoside provides both protective and reparative barrier support by stimulating tight-junction proteins (claudin-1, filaggrin). It's a core ingredient in barrier repair protocols.
Asiaticoside improves dermal density by increasing collagen I/III synthesis. Madecassoside, meanwhile, slows elastin degradation. Together, they create a more comprehensive anti-aging effect.
Madecassoside indirectly supports dermal hydration by encouraging hyaluronic acid synthesis. It strengthens moisture-retention capacity in sensitive, reactive skin.
Centella extracts or combination formulas containing both compounds show a broader effect spectrum than single-ingredient products. Ideal for preventive care and seasonal transitions.
What the Research Literature Shows
The clinical literature on Centella compounds has been steadily growing since the 1990s, reaching increasingly robust levels of evidence over time. Findings on Centella asiatica extract have included documented benefits for wound healing.Paocharoen, 2010 The points below summarize the directional findings reported across this body of research rather than a single controlled trial, and should be read as an evolving evidence base rather than fixed clinical guarantees.
What the Evidence Suggests About Madecassoside
- 1TEWL Reduction: Regular use of madecassoside-containing emulsions over several weeks has been associated with meaningful reductions in TEWL.
- 2Atopic Dermatitis: Madecassoside-based creams have shown benefit in easing atopic dermatitis severity scores over multi-week use.
- 3Rosacea and Redness: Users of madecassoside-containing formulas commonly report a noticeable easing of erythema and subjective redness over several weeks of consistent use.
- 4Filaggrin Expression: Madecassoside application has been linked to increased epidermal filaggrin expression relative to untreated skin.
What the Evidence Suggests About Asiaticoside
- 1Collagen Synthesis: Topical asiaticoside use has been associated with measurable increases in dermal collagen density over several weeks.
- 2Wound Healing: In post-surgical settings, asiaticoside-containing regimens have been associated with reduced scar formation compared to standard care.
- 3Stretch Marks: Regular use of asiaticoside during pregnancy has been studied for reducing new stretch-mark formation and improving the appearance of existing marks.
- 4Anti-Aging: Multi-week asiaticoside use has been associated with modest improvements in periorbital fine lines and skin elasticity.
Formulation Concentrations and Safety Profile
Both compounds are used in cosmetics with wide safety margins; but for optimal effectiveness, concentration ranges should align with tested clinical thresholds.
Recommended Use Concentrations
| Compound | Minimum Effective Concentration | Range Used in Clinical Studies | Maximum Cosmetic Limit |
|---|---|---|---|
| Madecassoside | 0.05% | 0.1% – 0.5% | 2% (in tolerance studies) |
| Asiaticoside | 0.1% | 0.2% – 1.0% | 2% (considered safe) |
| Full Centella Extract | 0.5% (dry extract) | 1% – 5% | 10% (well tolerated) |
Side Effect Profile
Both compounds are extremely well tolerated; serious side effects are rare. That said, a few points are worth keeping in mind:
- Contact sensitization: Asiaticoside can, rarely, cause contact allergy. Madecassoside shows a comparatively safer profile in this respect.
- Phototoxicity: No clinically significant phototoxicity has been established for either compound; however, sun protection shouldn't be skipped after applying to inflamed areas.
- Pregnancy and breastfeeding: Since systemic absorption from topical use stays very low, both compounds are generally considered safe; consulting a doctor first is still recommended.
Centella Compounds in the CIRÈLL Biomimetic TriBarrier System
The Biomimetic TriBarrier System developed by CIRÈLL doesn't reduce barrier repair to a single ingredient; instead, it brings together active molecules with different mechanisms of action at scientifically synergistic ratios. Madecassoside and asiaticoside form this system's "inflammation control and tissue renewal" arm within its three-layer barrier approach.
A Three-Layer Approach: Outside In
In the CIRÈLL approach, barrier repair is addressed through three simultaneous processes:
- Physical Barrier Reinforcement: Restoring ceramide, cholesterol, and fatty acid ratios to physiological levels — madecassoside's filaggrin stimulation supports this layer.
- Inflammation Control: Madecassoside's NF-κB suppression and TRPV1 inhibition, working alongside ectoin's osmotic stress buffering, help break the cycle of chronic micro-inflammation in sensitive skin.
- Tissue Renewal: Asiaticoside's TGF-β1 activation, combined with panthenol's epithelialization-accelerating effect, renews dermal density and epidermal integrity.
Within this framework, CIRÈLL formulas position madecassoside and asiaticoside as two distinct, complementary functional agents; both are declared separately by percentage on the label — because the ambiguity carried by the phrase "Centella extract" falls short for anyone seeking targeted dermocosmetic results. Synergy with other barrier supporters like ectoin is the core factor that sets CIRÈLL apart from ordinary Centella products.
Combination Strategies: Using Them Alongside Other Actives
Madecassoside and asiaticoside are compounds whose effectiveness can be meaningfully boosted with the right combinations. The wrong combinations, on the other hand, can reduce one ingredient's effectiveness or raise irritation risk.
Strong Synergies
| Combination Active | Synergy Mechanism | Recommended Skin Concern |
|---|---|---|
| Panthenol (Vitamin B5) | Accelerates epithelialization; complements madecassoside's barrier repair | Damaged barrier, post-procedure skin |
| Ectoin | Osmotic stress buffering + inflammation synergy | Sensitive skin, environmental stress exposure |
| Niacinamide | Stimulates ceramide synthesis + regulates sebum; supports asiaticoside's collagen effect | Combination-oily skin, enlarged pores |
| Hyaluronic Acid | Externally complements madecassoside's contribution to HA synthesis | Dehydrated, parched skin |
| Ceramide + Cholesterol | Parallel stratum corneum restoration alongside filaggrin stimulation | Atopic, barrier-damaged skin |
Combinations to Watch
High-concentration AHA/BHA acids (pH below 3.5) can negatively affect madecassoside's molecular stability and disrupt asiaticoside's metabolism. This is why it's recommended to separate the timing — Centella-containing products in the morning routine, acid-based exfoliants in the evening. This balance matters especially when considering the relationship between AHA/BHA and the skin barrier. When used alongside high-dose retinol, Centella compounds have shown a soothing effect on retinoid dermatitis — making this a barrier-supportive combination.
What These Signs on Your Skin Mean
The signs that suggest a need for Centella compounds often overlap with each other; the guide below shows which sign points to which compound.
Points to chronic micro-inflammation or a rosacea flare-up. Due to its NF-κB suppression and TRPV1 inhibition, madecassoside is the primary choice for this sign; noticeable easing of erythema can be expected with several weeks of consistent use.
Indicates post-inflammatory hyperpigmentation and scar tissue development. Asiaticoside's collagen-remodeling capacity and MMP regulation form the core mechanism for breaking the mark-forming cycle; an 8-12 week protocol is typically needed.
Reflects elevated TEWL and a disrupted stratum corneum. Madecassoside's filaggrin stimulation and tight-junction strengthening directly address this sign; combining it with panthenol speeds up the effect.
Shows that dermal collagen density has decreased and the elastin network has weakened. Asiaticoside's TGF-β1 activation increases fibroblast proliferation and improves the collagen I/III ratio; madecassoside slows collagen degradation by simultaneously reducing oxidative stress.
Conclusion
Madecassoside and asiaticoside are complementary molecules representing Centella asiatica's two distinct "specialties": one calms inflammation and repairs the barrier, the other renews tissue and drives collagen production. "Which one is better?" isn't the right question; the real question is: which process does your skin need more support with right now? For active redness and reactivity, madecassoside takes the lead; for scarring and loss of firmness, asiaticoside steps in. Most skin, though, benefits from both.
CIRÈLL's Biomimetic TriBarrier System is built on the simultaneous use of both compounds at clinically-informed concentrations. In the formulas that make up the system, madecassoside and asiaticoside percentages are declared separately — there's no hiding behind the ambiguity of "Centella extract." Our barrier repair guide walks through exactly which step and which products to use these compounds with.
Frequently Asked Questions
Madecassoside vs Asiaticoside: What's the Difference?
Madecassoside and asiaticoside are two different triterpene glycoside compounds found in the Centella asiatica plant; madecassoside stands out primarily for its anti-inflammatory and barrier-repair effects, while asiaticoside is distinguished by its capacity to stimulate collagen synthesis.
What is madecassoside and what does it do?
Madecassoside is a triterpene glycoside derived from the Centella asiatica plant. With a molecular weight of about 975 Da, this compound takes on two core functions in skin: first, by suppressing the NF-κB signaling pathway, it blocks release of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α; second, by increasing expression of the tight-junction proteins claudin-1 and filaggrin, it strengthens stratum corneum integrity. Because of these properties, madecassoside stands as a priority ingredient for reactive, sensitive, rosacea-prone, and barrier-damaged skin.
What is asiaticoside, and how is it different from madecassoside?
Asiaticoside is another glycoside from the same triterpene family as madecassoside, also derived from Centella asiatica; its molecular weight is ~959 Da. The main difference lies in mechanism of action: asiaticoside activates the TGF-β1 pathway to stimulate fibroblast proliferation and type I/III collagen synthesis — making it a compound that renews, firms, and reduces marks in the dermis. Madecassoside, by contrast, primarily calms inflammation and repairs the barrier. In short: madecassoside has a "soothing" profile, asiaticoside a "renewing" one; they're complementary, not competing.
How does madecassoside work — what's its mechanism?
Madecassoside's primary mechanism of action is suppression of the NF-κB (Nuclear Factor-kappa B) pathway. By blocking IκBα phosphorylation, it halts NF-κB's translocation into the nucleus, reducing pro-inflammatory gene expression. Alongside this, by inhibiting the TRPV1 channel, it calms the neurogenic inflammation responsible for burning, redness, and itching. On the barrier side, it strengthens both the physical and immunological layers of the epidermal barrier by increasing filaggrin and claudin-1 mRNA expression. The end result: TEWL values drop, and skin's water-retention capacity increases.
How does asiaticoside work — what's its relationship to collagen?
Asiaticoside activates TGF-β1 (Transforming Growth Factor-Beta 1) signaling in dermal fibroblasts. This activation increases synthesis of type I and type III collagen. Asiaticoside is also enzymatically converted in skin into asiatic acid, and this metabolite regulates matrix metalloproteinase (MMP) activity, helping prevent faulty collagen buildup. This dual mechanism makes asiaticoside effective both at preventing collagen loss and at remodeling existing scar tissue.
What percentage of madecassoside should cosmetic products contain?
While the minimum effective concentration for madecassoside in clinical studies has been established at 0.05%, the 0.1-0.5% range is recommended for meaningful barrier repair and anti-inflammatory effect. Tolerance studies have found it safe up to 2%; but the vast majority of cosmetic formulations work in the 0.1-0.3% band. If a product simply lists "Centella asiatica extract," it's not possible to know the madecassoside percentage inside; that's why quality dermocosmetic products should separately state the madecassoside percentage.
What concentration should asiaticoside be used at?
The minimum effective concentration for asiaticoside is considered to be 0.1%; most clinical studies have been conducted in the 0.2-1.0% range. Products in this range have been associated with measurable increases in dermal collagen density over several weeks of use. Cosmetic safety data confirms good tolerance up to 2%. But as with madecassoside, a "Centella extract" label gives no information about the asiaticoside amount; formulas with transparent dosage declarations should be preferred.
Can madecassoside and asiaticoside be used together?
Yes, a synergistic effect is observed when the two compounds are used together. Madecassoside's inflammation-control mechanism and asiaticoside's tissue-renewal capacity support each other: madecassoside calms the environment while asiaticoside advances collagen synthesis. Comparative studies against single-ingredient formulas have shown more pronounced improvement in the collagen I/III ratio with combination products. This is why the presence of both compounds together in quality dermocosmetic formulas is a deliberate formulation choice.
Which is more suitable for sensitive and reactive skin — madecassoside or asiaticoside?
Madecassoside should be the priority choice for sensitive and reactive skin. This is because madecassoside simultaneously calms both chemical inflammation (via NF-κB suppression) and neurogenic inflammation — burning, flushing (via TRPV1 inhibition). Asiaticoside, meanwhile, stimulates fibroblasts through TGF-β1 activation; during active inflammation, this stimulation can sometimes lower the threshold for mild redness. This is why it's more appropriate to lean on madecassoside during reactive periods, moving to a protocol combining both compounds once inflammation has settled.
Does asiaticoside or madecassoside offer more benefit for aging skin?
Both are beneficial in aging skin, for different reasons; asiaticoside takes priority for collagen loss and sagging, madecassoside for chronic oxidative inflammation and barrier weakening. Since both issues commonly coexist after age 40, combination formulas are generally preferred. Asiaticoside-containing formulas applied over 60 days have shown reductions in periorbital wrinkle depth alongside improvements in skin elasticity. Madecassoside, meanwhile, provides simultaneous cellular protection against oxidative stress.
Do Centella compounds become more important in winter?
Yes. In winter, cold air and low humidity noticeably raise transepidermal water loss (TEWL); central heating further lowers indoor humidity, leaving skin more exposed to dryness and reactivity. Under these environmental stress conditions, madecassoside's barrier-strengthening and anti-inflammatory effect gains particular value. During seasonal transitions (fall-winter), leaning toward madecassoside, and moving to a more balanced combination with asiaticoside in spring-summer, can be a practical strategy. No specific issue has been reported when combining either compound with sunscreen.
Are madecassoside or asiaticoside products expensive, and does their effectiveness justify the price?
Pure, isolated madecassoside or asiaticoside is more costly as a raw material compared to standard Centella extract; this is why products containing these compounds separately, at defined concentrations, tend to sit in the mid-to-upper price segment. But when evaluated for effectiveness, products manufactured at clinically-supported concentrations can reduce cosmetic and medical spending over the long term through their positive effects on barrier repair, inflammation control, and collagen synthesis. Products with transparent formulations that state madecassoside or asiaticoside percentage on the label should be preferred.
Do madecassoside and asiaticoside have side effects?
Both compounds have a high safety profile for cosmetic use. Reported side effects are extremely rare and mild. Asiaticoside can, in very rare cases, lead to contact allergy; madecassoside has a safer profile in this respect. Phototoxicity hasn't been clinically demonstrated for either compound; however, sunscreen use shouldn't be neglected after application to inflamed areas. Since systemic absorption is extremely low, topical use during pregnancy and breastfeeding is generally considered safe, though consulting a physician first is advised.
When should I see a doctor if Centella compounds aren't helping?
If, despite regular use of madecassoside- or asiaticoside-containing formulas, there's no meaningful improvement in redness, burning, flaking, or barrier signs after 8 weeks, you should seek an opinion from a dermatologist or dermocosmetologist. You should also seek care without delay in these situations: chronic weeping or oozing lesions, a steadily expanding irritated area, a suspected compound-specific allergic reaction (sudden swelling, burning, hives), or skin findings accompanied by fever or systemic symptoms. Centella compounds are powerful actives, but they can't substitute for conditions that require a dermatological diagnosis.
Should madecassoside or asiaticoside be used in the morning or evening?
Both compounds are suitable for morning and evening use; since they don't carry photosensitivity risk, there's no special restriction for morning application. That said, a recommended strategy: if the goal is active inflammation management or barrier repair, a madecassoside-forward serum or cream after morning cleansing, and a higher-asiaticoside or combination repair cream in the evening. If you use acid-based (AHA/BHA) exfoliants, these should be left for the evening, with Centella-containing products reserved for the morning or applied as a separate step after acid application.
How does madecassoside repair the skin barrier?
Madecassoside repairs the skin barrier through three distinct mechanisms. First, by increasing filaggrin expression, it restores the stratum corneum's water-retention capacity — filaggrin is the precursor for natural moisturizing factor (NMF) production. Second, by stimulating synthesis of the tight-junction proteins claudin-1 and occludin, it reduces intercellular permeability between keratinocytes. Third, by lowering TEWL values, it strengthens the epidermal "water-loss barrier." Together, these three effects provide both symptomatic relief and structural repair in barrier-damaged, atopic, and irritant-dermatitis-affected skin.
How long does it take to see results with asiaticoside versus madecassoside?
Madecassoside's anti-inflammatory effects (reduced redness, burning) generally start to be felt within 1-2 weeks; meaningful TEWL reduction for barrier repair is observed with 4 weeks of regular use. Asiaticoside's effects on collagen synthesis span a longer timeframe: increases in dermal density have been reported around the 8-week mark in clinical use, while reduction in wrinkle depth requires 8-12 weeks of use. For scar and mark treatment, a 12-16 week timeframe is a more realistic expectation. For both compounds, the best results come from consistent, daily use supported by sunscreen.
What should I look for when choosing a product with Centella asiatica?
The main thing to check when choosing a product containing Centella asiatica is whether the label separately states the madecassoside or asiaticoside percentage, rather than just "Centella asiatica extract." A "full-spectrum extract" or unspecified percentage tells you nothing about the product's active-ingredient amount. Beyond that, you should check the formulation's pH range (ideal for both compounds: 4.5-6.5), compatibility with accompanying actives (especially combination with acid-containing products), and the raw-material quality of the ingredient (certified sourcing). Brands that transparently declare madecassoside and asiaticoside in the dermocosmetic segment should be preferred.
References
- Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine. 2000;7(5):427-448.
- Maquart FX, Bellon G, Gillery P, Wegrowski Y, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica. Connect Tissue Res. 1990;24(2):107-120.
- Shukla A, Rasik AM, Dhawan BN. Asiaticoside-induced elevation of antioxidant levels in healing wounds. Phytother Res. 1999;13(1):50-54.
- Paocharoen V. The efficacy and side effects of oral Centella asiatica extract for wound healing promotion in diabetic wound patients. J Med Assoc Thai. 2010;93(Suppl 7):S166-70.
Further Reading
CIRÈLL Barrier Repair Cream
The scientific skin barrier principles discussed in this article form the foundation of the CIRÈLL Biomimetic Tribarrier Cream formulation.
View the Product